Results 241 to 250 of about 205,975 (308)

Impact of CD19 CAR T‐Cell Therapy on Pathogen‐Specific Antibody Titers in Lymphoma Patients

Transplant Infectious Disease, EarlyView.
Patients with lymphoma undergoing CD19 CAR T‐cell therapy experience prolonged hypogammaglobulinemia and B‐cell aplasia. We investigate its impact on immunity against measles virus (MeV), mumps virus (MuV), rubella virus (RuV), varicella‐zoster virus (VZV), pneumococcal capsular polysaccharide, Haemophilus influenzae type B (Hib), and tetanus toxoid ...
Hayley Foy‐Stones, Nicola Gardiner, Ellen Walsh, Derek G. Doherty, Anthony M. McElligott, Chris Armstrong, Nina Orfali, Robert Henderson, Elisabeth Vandenberghe, Elizabeth Higgins, Tor Hervig, Allison Waters, Brendan Crowley, Elizabeth Groarke, Niall P. Conlon, Christopher L. Bacon   +15 more
wiley   +1 more source

The safety of co-administration of recombinant zoster vaccine (Shingrix) and influenza vaccines in the elderly in VAERS during 2018-2024. [PDF]

Hum Vaccin Immunother
Li Y, Xia H, Zhang H, Lu Y, Zhou H, Yu R, Huang P.   +6 more
europepmc   +1 more source

Influenza vaccine—live

, 2013
Catherine J. Luke, Seema S. Lakdawala, Kanta Subbarao   +2 more
openaire   +1 more source

Higher uptake of common adult vaccines in Australian blood donors: An analysis of linked registry data

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Understanding differences in blood donor vaccine uptake is essential for accurately interpreting serosurveillance of vaccine‐preventable diseases and other research using donor samples and/or data. We aimed to assess vaccination uptake in donors and non‐donors.
Surendra Karki, Veronica Hoad, Bette Liu, Marijke Welvaert, Rena Hirani, David O. Irving   +5 more
wiley   +1 more source

Longitudinal Surveillance of Influenza A Virus Exposure in Wild Boars (Sus scrofa) in Spain (2015–2023): Serologic and Virologic Evidence of Subtype Infections and H5N1 Spillover Risk

Zoonoses and Public Health, EarlyView.
ABSTRACT Introduction Influenza A viruses (IAVs) are responsible for respiratory infections in a wide range of species, including birds, swine and humans. The role of wild boar (Sus scrofa) in IAV epidemiology remains underexplored. Here, we present a longitudinal serologic and virologic surveillance study of wild boars in Spain from 2015 to 2023 ...
Paloma Encinas, Aitor Nogales, Estela Escribano‐Romero, M. Ángeles Martín del Burgo, Jorge Ramón López‐Olvera, José Enrique Granados, Gregorio Mentaberre, Adolfo García‐Sastre, Gustavo del Real   +8 more
wiley   +1 more source

Estimated Relative Effectiveness and Public Health Impact of Cell-Based Versus Egg-Based Influenza Vaccines During the 2022-2023 Season in the United States. [PDF]

Influenza Other Respir Viruses
Stein AN, Thanataveerat A, McDermott KW, Dean A, Wall S, Pack C, Sullivan SG, McGovern I, Haag MDM.   +8 more
europepmc   +1 more source

A Retrospective Cross‐Sectional Study (2009–2023): Exploring Influenza A(H1N1)pdm09 Antibody Time Series in Humans and Swine and Vaccine Coverage in Two Target Groups

Zoonoses and Public Health, EarlyView.
ABSTRACT Introduction Swine may act as ‘epidemiological bridges’ and reservoirs for the emergence of novel zoonotic influenza viruses with pandemic potential. While bidirectional exchange of influenza A viruses at the swine–human interface is well recognised, data on the extent of interspecies transmission are limited.
Solveig Jore, Ragnhild Tønnessen, Carl Andreas Grøntvedt, Kjersti Rydland, Anna Germundsson Hauge, Olav Hungnes, Anja Bråthen Kristoffersen, Even Fossum   +7 more
wiley   +1 more source

Relative Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccines in Preventing Hospitalizations: A National Retrospective Cohort Study in France, 2022/2023 Season. [PDF]

Influenza Other Respir Viruses
Bricout H, Levant MC, Crépey P, Gavazzi G, Gaillat J, Dufournet M, Assi N, Grenier B, Raguideau F, Péretz F, Salamand C, Mosnier A, Watier L, Launay O, Loiacono MM.   +14 more
europepmc   +1 more source

The potential global health impact and cost-effectiveness of next-generation influenza vaccines: A modelling analysis. [PDF]

PLoS Med
Goodfellow L, Procter SR, Koltai M, Waterlow NR, Filipe JAN, Wong CKH, van Leeuwen E, Eggo RM, Jit M, WHO Technical Advisory Group for the Full Value of Influenza Vaccines Assessment and project team, Next-generation influenza vaccine impact modelling contributors.   +10 more
europepmc   +1 more source

Development Strategies for Influenza Vaccines Utilizing Phage RNA Polymerase and Capping Enzyme NP868R. [PDF]

Chem Bio Eng
Wang W, Ma Z, Lou Q, Li T, Huang Z, Yin W, Lou C, Xiang Y.   +7 more
europepmc   +1 more source